Preoperative systemic immune-inflammation index predicts prognosis of patients with oral squamous cell carcinoma after curative resection

被引:49
|
作者
Diao, Pengfei [1 ]
Wu, Yaping [1 ]
Li, Jin [1 ]
Zhang, Wei [2 ]
Huang, Rong [1 ]
Zhou, Chen [3 ]
Wang, Yanling [1 ]
Cheng, Jie [1 ,2 ]
机构
[1] Nanjing Med Univ, Jiangsu Key Lab Oral Dis, 136 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Affiliated Stomatol Hosp, Dept Oral & Maxillofacial Surg, Nanjing 210029, Jiangsu, Peoples R China
[3] Jiangnan Univ, Affiliated Hosp, Dept Oral & Maxillofacial Surg, Wuxi 214000, Jiangsu, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
Oral squamous cell carcinoma; Prognostic biomarker; Systemic immune-inflammation index; LYMPHOCYTE RATIO; CAVITY; CANCER; TUMORS; BIOMARKER; PLATELET;
D O I
10.1186/s12967-018-1742-x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundDeregulated inflammation and immune deficit both intricately associate with cancer initiation and progression, which have been increasingly exploited as prognostic biomarkers and therapeutic targets. Recently, systemic immune-inflammation index (SII) based on peripheral neutrophil, lymphocyte and platelet counts serves as a novel and powerful cancer biomarker with prognostic significance in multiple types of malignancies. Here, we sought to evaluate the prognostic value of preoperative SII in patients with primary oral squamous cell carcinoma (OSCC) after curative resection.MethodsTwo independent cohorts with a total number of 309 patients with OSCC from two tertiary referral hospitals were included and defined as training (Nanjing, 138) and validation (Wuxi, 171) cohort, respectively. Preoperative SII in both cohorts was calculated and its optimal cutoff value was initially determined by X-tile software in the training cohort and then verified in the validation cohort.ResultsOur data indicated that high SII (484.5) was significantly associated with larger tumor size (P<0.05, Chi square test), reduced overall and disease-free survival (Kaplan-Meir, P<0.05, Log-rank test). Univariate and multivariate analyses further revealed that SII was an independent prognostic predictor for patient survival. Moreover, the area under receiver operating characteristic curve of SII for survival was significantly greater or comparable to other well-established prognostic parameters, indicative of its satisfactory prediction accuracy and specificity.ConclusionsOur findings reveal that high preoperative SII associates with poor outcome and serves as a non-invasive, low-cost and powerful prognostic predictor for patients with OSCC. This inflammation/immune-related biomarker holds translational potentials to supplement currently prognostic regime to better stratification of patients and treatment planning.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Systemic immune-inflammation index predicts prognosis of sequential therapy with sorafenib and regorafenib in hepatocellular carcinoma
    Hong, Young Mi
    Yoon, K. T.
    Cho, Mong
    [J]. BMC CANCER, 2021, 21 (01)
  • [32] Systemic immune-inflammation index during treatment predicts prognosis and guides clinical treatment in patients with nasopharyngeal carcinoma
    Xiaofei Yuan
    Huiru Feng
    Haoran Huang
    Junzheng Li
    Shuting Wu
    Yue Yuan
    Linchong Cui
    Danfan Lin
    Zilu Chen
    Wenxuan Lu
    Xiong Liu
    Xiaohong Peng
    Fan Wang
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 191 - 202
  • [33] Systemic immune-inflammation index predicts prognosis of sequential therapy with sorafenib and regorafenib in hepatocellular carcinoma
    Young Mi Hong
    K. T. Yoon
    Mong Cho
    [J]. BMC Cancer, 21
  • [34] Systemic immune-inflammation index during treatment predicts prognosis and guides clinical treatment in patients with nasopharyngeal carcinoma
    Yuan, Xiaofei
    Feng, Huiru
    Huang, Haoran
    Li, Junzheng
    Wu, Shuting
    Yuan, Yue
    Cui, Linchong
    Lin, Danfan
    Chen, Zilu
    Lu, Wenxuan
    Liu, Xiong
    Peng, Xiaohong
    Wang, Fan
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (01) : 191 - 202
  • [35] Systemic Immune-Inflammation Index Predicts Tumor Recurrence after Radical Resection for Colorectal Cancer
    Nakamoto, Shuji
    Ohtani, Yoshimasa
    Sakamoto, Izumi
    Hosoda, Atsushi
    Ihara, Atsushi
    Naitoh, Takeshi
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2023, 261 (03): : 229 - 238
  • [36] Prognostic and clinicopathological role of pretreatment systemic immune-inflammation index in patients with oral squamous cell carcinoma: a meta-analysis
    Zhang, Jiliang
    Dai, Shu
    [J]. FRONTIERS IN ONCOLOGY, 2024, 13
  • [37] Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus
    Feng, Ji-Feng
    Chen, Sheng
    Yang, Xun
    [J]. MEDICINE, 2017, 96 (04)
  • [38] Systemic immune-inflammation index predicts prognosis in patients with epithelial ovarian cancer: A retrospective study
    Nie, Dan
    Gong, Han
    Mao, Xiguang
    Li, Zhengyu
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 152 (02) : 259 - 264
  • [39] Systemic immune-inflammation index predicts postoperative acute kidney injury in hepatocellular carcinoma patients after hepatectomy
    Xu, Jianjun
    Hu, Shaobo
    Li, Suzhen
    Wang, Weimin
    Wu, Yuzhe
    Su, Zhe
    Zhou, Xing
    Gao, Yang
    Cheng, Xiang
    Zheng, Qichang
    [J]. MEDICINE, 2021, 100 (14) : E25335
  • [40] Chromobox 2 Expression Predicts Prognosis After Curative Resection of Oesophageal Squamous Cell Carcinoma
    Ueda, Sei
    Kanda, Mitsuro
    Sato, Yusuke
    Baba, Hayato
    Nakamura, Shunsuke
    Sawaki, Koichi
    Shimizu, Dai
    Motoyama, Satoru
    Fujii, Tsutomu
    Kodera, Yasuhiro
    Nomoto, Shuji
    [J]. CANCER GENOMICS & PROTEOMICS, 2020, 17 (04) : 391 - 400